# Hospice Quality Score Assessment Post Pharmacist Intervention

> **NCT04361669** · — · WITHDRAWN · sponsor: **Tabula Rasa HealthCare**

## Conditions studied

- Respiratory Disease
- Cardiovascular Diseases
- Neurologic Disorder
- Dementia
- Cancer

## Interventions

- **OTHER:** Medication safety review

## Key facts

- **NCT ID:** NCT04361669
- **Lead sponsor:** Tabula Rasa HealthCare
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-04-22
- **Primary completion:** 2022-09-01
- **Final completion:** 2022-09-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Change in study personnel and sponsor.
- **Last updated:** 2022-09-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04361669

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04361669, "Hospice Quality Score Assessment Post Pharmacist Intervention". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04361669. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*